Chesapeake Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406 Hold
30
﹤0.01% 370
2026
Q1
$179 Hold
30
﹤0.01% 325
2025
Q4
$215 Hold
30
﹤0.01% 349
2025
Q3
$320 Hold
30
﹤0.01% 306
2025
Q2
$290 Sell
30
-5
-14% -$52 ﹤0.01% 310
2025
Q1
$521 Hold
35
﹤0.01% 434
2024
Q4
$522 Hold
35
﹤0.01% 396
2024
Q3
$669 Hold
35
﹤0.01% 345
2024
Q2
$724 Hold
35
﹤0.01% 304
2024
Q1
$658 Sell
35
-270
-89% -$4.63K ﹤0.01% 293
2023
Q4
$4.4K Hold
305
﹤0.01% 310
2023
Q3
$5.29K Sell
305
-400
-57% -$8.34K 0.01% 306
2023
Q2
$14.7K Sell
705
-80
-10% -$1.74K 0.01% 224
2023
Q1
$18.5K Buy
+785
New +$21.1K 0.02% 196

Other funds holding OGN

Chesapeake Asset Management's OGN Position: Q2 2026 in Review

Chesapeake Asset Management held its Organon & Co (OGN) position steady in Q2 2026 at 30 shares worth $406. The position accounts for ﹤0.01% of the portfolio, ranked #370.

Chesapeake Asset Management first reported a position in OGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $18.5K in Q1 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Chesapeake Asset Management held 30 shares of Organon & Co worth $406 as of Q2 2026.
  • Chesapeake Asset Management left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #370 holding.
  • Chesapeake Asset Management first reported a position in Organon & Co in Q1 2023 and has held it in 14 quarters since.
  • Chesapeake Asset Management's Organon & Co position peaked at $18.5K in Q1 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.